*Subject to change


Thursday, June 17, 2021

GiHF Leadership Summit


1:00–5:00 PM

Disease State Breakouts: State of the Art in Diagnosis, Management, and Treatment

Industry Forums

6:00–8:00 PM

Welcome Reception with Industry Sponsors

Friday, June 18, 2021

6:40–7:30 AM 

Breakfast Product Theater (Non-Accredited)

Sponsored by Ferring Pharmaceuticals

Presented by Carl Crawford, MD

Session I

8:00–8:05 AM


Stephen Hanauer, MD

8:05–8:20 AM

Traditional vs. Regional Definitions of IBD

Dermot McGovern, MD


8:20–8:35 AM

Current Treatment Algorithms & Management of Comorbidities

Anita Afzali, MD

8:35–8:50 AM

Practical Applications of Treat to Target in Practice

Uma Mahadevan, MD

8:50–9:05 AM

Precision Medicine in IBD

Maria Abreu, MD

9:05–9:20 AM

Q&A Panel Discussion

9:20–9:30 AM


9:30–9:55 AM

Relevance of Real-World Data

Millie Long, MD

9:55–10:10 AM       

Positioning Current and Future Therapies in IBD

Gary Lichtenstein, MD

10:10–10:25 AM            

Combining MOAs  

Asher Kornbluth, MD

10:25–10:35 AM     

Q&A Panel Discussion

10:35–10:45 AM



10:45–11:00 AM         

Evolution of GERD Management Beyond 2021

Prateek Sharma, MD


11:00–11:15 AM          

What's New in GI Pharmacology

Philip Schoenfeld, MD, MSEd, MSc (Epi)

11:15–11:30 AM         

Eosinophilic GI Disorders

Ikuo Hirano, MD

11:30–11:45 AM   

Evolving Role of Microbial Modifications in C. difficile Infection

Paul Feuerstadt, MD

11:45 AM–12:00 PM       

Gastroparesis and Complex Motility Issues

Linda Nguyen, MD

12:00–12:15 PM

Q&A Panel Discussion

12:45–1:35 PM       

Lunch Product Theater (Non-Accredited) 

Sponsored by Phathom Pharmaceuticals

Presented by Brooks Cash, MD

Saturday, June 19, 2021

Session II

9:00–9:10 AM


Darren Brenner, MD

9:10–9:25 AM

Pathophysiology of IBS: Predisposing Factors and the Role of Gut-Brain Interactions 

Lin Chang, MD


9:25–9:40 AM

Reducing the 4–5: Diagnosing IBS in 4–5 Minutes and with 4–5 Tests 

Darren Brenner, MD

9:40–9:55 AM

Pharmacotherapy for IBS-C/CIC: The Role of OTCs vs. Prescription Therapies 

Brooks Cash, MD

9:55–10:10 AM

Pharmacotherapy for IBS-D

Lucinda Harris, MD 


10:10–10:35 AM

Q&A Panel Discussion

10:35–10:45 AM


10:45–11:00 AM

Natural Treatments for IBS: Biotics, Food, and Fiber

William Chey, MD 

11:00–11:15 AM

Psychogastroenterology: The Role of Behavioral Intervention in IBS 

Laurie Keefer, PhD

11:15–11:30 AM

Controversies and Updates in IBS Guidelines: ACG and AGA IBS-D

Baharak Moshiree, MD 

11:30–11:55 AM

Q&A Panel Discussion

11:55 AM–12:00 PM

Closing Remarks and Final Adjournment

Exhibit Hall will open on Thursday, June 17th at 6:00 PM and remain open during all GI ReConnect sessions.